Scott Steiger • UCSF Profiles

Scott Steiger, MD

Title(s)	Professor, Medicine
School	School of Medicine
Address	995 Potrero Avenue, #312 San Francisco CA 94110
vCard	Download vCard

Biography

Education and Training

University of Washington	Residency	2008	Internal Medicine
Washington University	M.D.	2005
Duke University	B.S.	1998	Biology and History

Awards and Honors

UCSF Academy of Medical Educators	2020	Excellence in Interprofessional Teaching Award
Association for Medical Education and Research on Substance Abuse	2016	Best Workshop
UCSF Academy of Medical Educators	2015	Excellence in Teaching Award
American College of Physicians	2015	Fellow
American Society of Addiction Medicine	2015	Fellow

Overview

Since growing up in southeastern Kansas, Dr. Steiger has moved all over the country for school and jobs, landing on faculty at UCSF in 2012 at the Mt. Zion campus and transitioning to the San Francisco General campus in 2016. Board-certified in both internal medicine and addiction medicine, Dr. Steiger is the Deputy Medical Director of the Opiate Treatment Outpatient Program at SF General, where he also maintains a primary care practice and attends on the inpatient Addiction Care Team. His primary academic interest is in teaching about addiction and its treatments.

In The News

	Is Government Regulation Keeping Americans From Getting Addiction Care? (03/22/2019)
	Safe Injection Sites (KQED Newsroom) (09/07/2018)
	California's Opioid Crisis (KQED Newsroom) (05/11/2018)

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Induction to Methadone 80 mg in the First Week of Treatment of Patients Who Use Fentanyl: A Case Series From an Outpatient Opioid Treatment Program. J Addict Med. 2024 Sep-Oct 01; 18(5):580-585. Steiger S, McCuistian C, Suen LW, Shapiro B, Tompkins DA, Bazazi AR. PMID: 39150067; PMCID: PMC11446640.

View in: PubMed Mentions: Fields:
Sub Substance-Related Disorders
Translation:Humans
"Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment. Int J Drug Policy. 2023 Nov; 121:104214. Suen LW, Steiger S, Shapiro B, Castellanos S, Joshi N, Lambdin BH, Knight KR. PMID: 37778132.

View in: PubMed Mentions: 2 Fields:
Pub Public Health Sub Substance-Related Disorders
Translation:Humans
Predictors of Linkage to an Opioid Treatment Program and Methadone Treatment Retention following Hospital Discharge in a Safety-Net Setting. Subst Use Misuse. 2023; 58(9):1172-1176. Tierney HR, Takimoto SW, Azari S, Steiger S, Martin M. PMID: 37194561.

View in: PubMed Mentions: 1 Fields:
Sub Substance-Related Disorders
Translation:Humans
Adapting methadone inductions to the fentanyl era. J Subst Abuse Treat. 2022 10; 141:108832. Buresh M, Nahvi S, Steiger S, Weinstein ZM. PMID: 35870437.

View in: PubMed Mentions: 16 Fields:
Sub Substance-Related Disorders
Translation:Humans
"I wanted something that was more flexible": A qualitative study of patient preferences on choosing buprenorphine over methadone in a large, safety-net hospital opioid treatment program. Subst Abus. 2022; 43(1):767-773. Checkley L, Steiger S, Knight KR. PMID: 35112998.

View in: PubMed Mentions: 3 Fields:
Sub Substance-Related Disorders
Translation:Humans
Time to ACT: launching an Addiction Care Team (ACT) in an urban safety-net health system. BMJ Open Qual. 2021 01; 10(1). Martin M, Snyder HR, Coffa D, Steiger S, Clement JP, Ranji SR, Azari S, Nguyen OK, Lum PJ. PMID: 33500326; PMCID: PMC7843300.

View in: PubMed Mentions: 7 Fields:
Hea Health Services Research
Translation:Humans
What Should I Know About Opioids? JAMA Intern Med. 2019 07 01; 179(7):1012. Incze MA, Steiger S. PMID: 30882852.

View in: PubMed Mentions: 1 Fields:
Int Internal Medicine
Translation:Humans
Increasing Naloxone Co-prescription for Patients on Chronic Opioids: a Student-Led Initiative. J Gen Intern Med. 2018 06; 33(6):797-798. Freise JE, McCarthy EE, Guy M, Steiger S, Sheu L. PMID: 29556799; PMCID: PMC5975169.

View in: PubMed Mentions: 4 Fields:
Int Internal Medicine
Translation:Humans
Predictors of higher-risk chronic opioid prescriptions in an academic primary care setting. Subst Abus. 2016; 37(1):110-7. Bauer SR, Hitchner L, Harrison H, Gerstenberger J, Steiger S. PMID: 26848633.

View in: PubMed Mentions: 6 Fields:
Sub Substance-Related Disorders
Translation:Humans PHPublic Health
Teaching residents screening, brief intervention, and referral to treatment (SBIRT) skills for alcohol use: Using chart-stimulated recall to assess curricular impact. Subst Abus. 2016 Jul-Sep; 37(3):419-426. Wamsley MA, Steiger S, Julian KA, Gleason N, O'Sullivan PS, Guy M, Satterfield JM. PMID: 26675123.

View in: PubMed Mentions: 5 Fields:
Sub Substance-Related Disorders
Translation:Humans
Cultural Adaptation of Screening, Brief Intervention and Referral to Treatment Using Motivational Interviewing. J Addict Med. 2015 Sep-Oct; 9(5):352-7. Satre DD, Manuel JK, Larios S, Steiger S, Satterfield J. PMID: 26428360; PMCID: PMC4825851.

View in: PubMed Mentions: 4 Fields:
Sub Substance-Related Disorders
Translation:Humans